"In mice" is the right caveat for outcomes and the wrong one for mechanisms. Nobody’s selling you a drug here--they’re describing a chromatin change, and that’s the part rodents are actually good for.

The alternative study design is randomizing infants to early-life stress and biopsying their hippocampi at 30. Committee’s still reviewing it.